PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human NTRK2 (TrkB) (carrier-free), 100 µg
Recombinant Human Oncostatin M (Animal-Free), 10 μg
Recombinant Human Oncostatin M (carrier-free), 10 μg
Recombinant Human Oncostatin M (carrier-free), 100 μg
Recombinant Human Oncostatin M (carrier-free), 25 μg
Recombinant Human Osteopontin (carrier-free), 10 µg
Recombinant Human Osteopontin (carrier-free), 100 µg
Recombinant Human Osteopontin (carrier-free), 25 µg
Recombinant Human OX40L (carrier-free), 100 μg
Recombinant Human OX40L (carrier-free), 25 μg
Recombinant Human PCSK9 (carrier-free), 10 μg
Recombinant Human PCSK9 (carrier-free), 100 μg
Recombinant Human PCSK9 (carrier-free), 25 μg
Recombinant Human PCSK9 (carrier-free), 500 μg
Recombinant Human PDGF-AA (Animal-Free), 10 μg
Recombinant Human PDGF-BB (carrier-free), 10 μg